SLC16A3 and carcinoma: In this model, reprogrammed CAFs adopt a glycolytic phenotype, upregulate MCT4 and secrete high energy metabolites such as lactate to the extracellular space, providing a nutrient-rich microenvironment to carcinoma cells.